• HHS Office of Inspector General Seeks Input on Compliance Guidance for Recipients of NIH Research Grants
  • October 14, 2003 | Authors: Kendra Dimond;
  • Law Firm: Epstein Becker & Green, P.C. - Washington Office
  • The Office of Inspector General ("OIG") of the Department of Health and Human Services ("HHS") is seeking comments from the interested public as it develops a draft compliance program guidance for recipients of extramural research grant and cooperative agreement awards from the National Institutes of Health ("NIH"). The notice was published on Friday, September 5, 2003 in the Federal Register (Volume 68, No. 172, at page 52783), and is available on the Internet at http://www.oig.hhs.gov/authorities/docs/FRcpgNIHsolicitation.pdf. Comments are due by November 4, 2003. The purpose of OIG compliance guidance is to assist recipient organizations in promoting compliance with federal program requirements and thereby prevent fraud and abuse. The suggestions in OIG guidances are not mandatory, and they do not represent an exhaustive listing of the elements of a strong compliance program. OIG guidances can, however, provide a framework for organizations to use in developing their own internal compliance programs. The OIG previously has issued eleven compliance guidance documents for the health care industry, most recently addressing the practices of pharmaceutical manufacturers. To view the finalized pharmaceutical industry guidance in order to ascertain the approach taken by these guidances, go to http://www.oig.hhs.gov/fraud/docs/complianceguidance/042803pharmacymfgnonfr.pdf.